CORONA REMEDIES
Back to Balance Sheet
|
CORONA REMEDIES Last 5 Year Book Value History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|---|
| Adjusted Book Value | 122.12 | 99.14 | 78.55 | 66.80 |
What is the latest Book Value ratio of CORONA REMEDIES ?
| Year | Book Value |
|---|---|
| Mar2026 | 122.12 |
| Mar2025 | 99.14 |
| Mar2024 | 78.55 |
| Mar2023 | 66.80 |
How is Book Value of CORONA REMEDIES Trending?
| Years | Book Value | % Change | |
|---|---|---|---|
| Mar2026 | 122.12 | 23.18 | |
| Mar2025 | 99.14 | 26.21 | |
| Mar2024 | 78.55 | 17.59 | |
| Mar2023 | 66.80 | - | |
Compare Book Value of peers of CORONA REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CORONA REMEDIES | ₹13,556.1 Cr | 7.8% | 7.8% | NA | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,991.0 Cr | 1.1% | -4.2% | 4.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹256,310.0 Cr | 7.5% | 1.3% | 45.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,604.0 Cr | 1.8% | -6.3% | 26.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,722.0 Cr | 9.3% | 9.5% | 4.3% | Stock Analytics | |
| CIPLA | ₹109,628.0 Cr | 1.5% | -2.3% | -17.3% | Stock Analytics | |
CORONA REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CORONA REMEDIES | 7.8% |
7.8% |
|
| SENSEX | 1.2% |
0.4% |
-12.2% |
You may also like the below Video Courses